Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine and Stellate Ganglion Blocks for TBI-Associated Headaches and PTSD
NCT06608277Phase 2Recruiting
- Sponsor
- Northwestern University
- Start
- Jul 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in post-traumatic headache (PTH), post-traumatic stress disorder (PTSD), sponsored by Northwestern University. Started Jul 2025; status: recruiting.
02
Drugs
ketamine
03
Conditions
post-traumatic headache (PTH)post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT06608277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06608277.